LCTX · Lineage Cell Therapeutics, Inc. · Proposed Sales
$0.94
+0.01 (+1.13%)
At close · Oct 6
View the 10-K filed Mar 5, 2026
Return incl. dividend (before tax)
Customer concentration
— top 2 customers 92% of revenue
2 customers — 92% of revenue (the year ended December 31, 2025)
“For the year ended December 31, 2025, the Company’s top two customers collectively represented 92% of the Company’s total revenue.”
One customer — 92% of revenue (the year ended December 31, 2024)
“For the year ended December 31, 2024, the Company's top single customer represented 92% of the Company’s total revenue.”
Market Cap
$260.49M
Shares
252.91M
Volume · Oct 6
967.62K
Avg daily vol (3M)
1.14M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
Showing 1–2 of 2 filings